Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.
- NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_assertion description "[Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.
- NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_assertion evidence source_evidence_literature NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.
- NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_assertion SIO_000772 11460166 NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.
- NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_assertion wasDerivedFrom befree-2016 NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.
- NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_assertion wasGeneratedBy ECO_0000203 NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.
- befree-2016 importedOn "2016-02-19" NP324288.RABW4tBvh3ic0nWUGcV9JIKsv9rDyopa5vTYxDIMDjdRM130_provenance.